Skip to main content

View full-text article in PMC

. 2012 May 4;7(5):e36476. doi: 10.1371/journal.pone.0036476

Table 5. Monoamine transport inhibition.

	SERT	NET	DAT
	K_i (µM) (95% CI)	K_i (µM) (95% CI)	K_i (µM) (95% CI)
MDMA^*	1.40 (1.00–1.96)	0.470 (0.334–0.598)	16.7 (11.5–24)
MDA^*	2.41 (1.49–3.92)	0.341 (0.253–0.461)	11 (7.5–17)
Duloxetine	0.050 (0.04–0.07)^*	0.126 (0.099–0.161)^*	2.26 (0.7–3.8)^#
Reboxetine	2.07 (1.4–2.6)^#	0.036 (0.030–0.044)^*	16.4 (11.5–25.2)^#
Citalopram^*	0.045 (0.037–0.057)	>20	>20
Indatraline^#	0.09 (0.06–0.12)	0.043 (0.03–0.06)	0.025 (0.01–0.04)
Paroxetine^#	0.014 (0.01–0.02)	1.12 (0.03–1.7)	4.83 (2.4–7.3)

^*

method A; ^#method B; 95% CI, 95% confidence interval; values are significantly different (p<0.05) if 95% CI do not operlap.